Prognostic Factors in Alcohol-associated Liver Disease Patients Presenting With First Evidence of Ascites.
Khalid Fahoum, Nicole T Shen, Elora Basu...
https://pubmed.ncbi.nlm.nih.gov/37126326/Actively Recruiting
Led by Nicole T Shen · Updated on 2019-03-13
160
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to study alcohol recidivism in adults diagnosed with alcoholic liver disease, including acute alcoholic hepatitis or alcoholic cirrhosis. The purpose is to better understand patterns of alcohol use over time in this population. This observational study is conducted at Weill Cornell Medical Center, Columbia University Medical Center New York Presbyterian Hospital, and the Gastroenterology and Hepatology Clinic. Participants with alcoholic liver disease who consent to join will complete surveys at the start and then at 3, 6, 9, 12, 15, and 18 months, followed by assessments at 2, 5, and 10 years. There is no treatment or intervention given, and all participants undergo the same survey schedule. The study also includes clinical interviews and tests, such as urine ethyl glucuronide or blood ethanol testing, to measure alcohol recidivism. During the study, participants will be asked to complete surveys and participate in clinical interviews either in person or by phone at scheduled intervals. Researchers will also review medical records to track alcohol use. The main outcomes measured are alcohol recidivism assessed by questionnaires, clinical interviews, and biological testing at 6 months and beyond. The study monitors participants for up to 10 years to gather long-term data on alcohol use behavior.
CONDITIONS
Evaluating Alcohol Use in Alcoholic Liver Disease
N
Nicole T Shen, MD
R
Robert S Brown, MD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nicole T Shen
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or phone)
Duration - At enrollment
Participants complete an initial survey and baseline assessments to evaluate alcohol use and liver disease status.
1 baseline visit (in-person or phone)
Duration - Up to 10 years
Participants are followed over time with surveys and clinical interviews to monitor alcohol recidivism and liver disease progression.
Surveys and interviews at 3, 6, 9, 12, 15, and 18 months, then at 2, 5, and 10 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Khalid Fahoum, Nicole T Shen, Elora Basu...
https://pubmed.ncbi.nlm.nih.gov/37126326/Nicole T Shen
Lead Sponsor